We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$220M
AUM Growth
+$65.3M
Cap. Flow
+$74.6M
Cap. Flow %
33.91%
Top 10 Hldgs %
28.53%
Holding
203
New
50
Increased
127
Reduced
16
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 10.37%
2 Healthcare 9.03%
3 Financials 7.61%
4 Consumer Discretionary 4.79%
5 Real Estate 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVW icon
1
iShares S&P 500 Growth ETF
IVW
$73.8B
$9.85M 4.47%
219,744
+43,480
+25% +$1.91M
SCHB icon
2
Schwab US Broad Market ETF
SCHB
$43.2B
$7.3M 3.32%
+617,280
New +$7.13M
QQQ icon
3
Invesco QQQ Trust
QQQ
$453B
$6.14M 2.79%
32,886
+8,573
+35% +$1.58M
SCHX icon
4
Schwab US Large- Cap ETF
SCHX
$71.8B
$6.11M 2.78%
+518,760
New +$5.96M
DIA icon
5
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$5.85M 2.66%
22,003
+5,792
+36% +$1.51M
IVE icon
6
iShares S&P 500 Value ETF
IVE
$49B
$5.81M 2.64%
49,842
+13,126
+36% +$1.5M
AVGO icon
7
Broadcom
AVGO
$1.85T
$5.8M 2.64%
227,950
+56,410
+33% +$1.64M
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$5.72M 2.6%
19,524
+3,012
+18% +$867K
IYR icon
9
iShares US Real Estate ETF
IYR
$4.66B
$5.72M 2.6%
65,560
+17,625
+37% +$1.54M
EHC icon
10
Encompass Health
EHC
$11B
$4.49M 2.04%
91,428
+5,379
+6% +$261K
VER
11
DELISTED
VEREIT, Inc.
VER
$4.42M 2.01%
118,390
+86,376
+270% +$3.74M
LLY icon
12
Eli Lilly
LLY
$1.02T
$4.09M 1.86%
35,456
+7,418
+26% +$874K
VOO icon
13
Vanguard S&P 500 ETF
VOO
$979B
$3.85M 1.75%
14,311
+2,495
+21% +$660K
INTC icon
14
Intel
INTC
$455B
$3.66M 1.66%
77,970
+17,427
+29% +$864K
FSK icon
15
FS KKR Capital
FSK
$2.96B
$3.61M 1.64%
152,869
+91,268
+148% +$2.24M
CWB icon
16
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
$3.34M 1.52%
65,965
+32,392
+96% +$1.7M
LRCX icon
17
Lam Research
LRCX
$367B
$2.82M 1.28%
206,110
+66,560
+48% +$1.26M
RSPT icon
18
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
$2.8M 1.27%
+154,830
New +$2.68M
SCHD icon
19
Schwab US Dividend Equity ETF
SCHD
$103B
$2.75M 1.25%
+154,008
New +$2.71M
JNJ icon
20
Johnson & Johnson
JNJ
$618B
$2.73M 1.24%
21,042
+2,184
+12% +$302K
SCHG icon
21
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$2.65M 1.21%
253,136
-58,624
-19% -$596K
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
$2.58M 1.17%
37,872
+1,327
+4% +$70.5K
ARI
23
Apollo Commercial Real Estate
ARI
$867M
$2.55M 1.16%
152,735
+28,184
+23% +$525K
JPM icon
24
JPMorgan Chase
JPM
$935B
$2.41M 1.1%
24,503
+3,596
+17% +$396K
TXN icon
25
Texas Instruments
TXN
$252B
$2.29M 1.04%
23,863
+4,884
+26% +$546K

Similar funds

Kalos Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kalos Management held 203 positions worth $220M, up 42% from $155M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Kalos Management deployed $74.6M of net new capital in Q2 2019, opening 50 new positions and adding to 127 existing holdings. Its largest new stake was Schwab US Broad Market ETF: 617,280 shares worth $7.3M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.95M trimmed.

  • Kalos Management's largest Q2 2019 buy was Schwab US Broad Market ETF: 617,280 shares worth $7.3M.
  • Kalos Management added most to VEREIT, Inc. in Q2 2019, an estimated $3.74M increase.
  • Kalos Management's biggest Q2 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.95M.
  • Kalos Management fully exited Procter & Gamble in Q2 2019, selling an estimated $273K.
  • Kalos Management's ten largest holdings make up 29% of its $220M portfolio in Q2 2019.
  • Kalos Management opened 50 new positions and closed 9 in Q2 2019.
  • Kalos Management's portfolio value rose 42% quarter-over-quarter to $220M.

Based on Kalos Management's 13F filing for Q2 2019, filed 14 Aug 2019.